Does Rallies show 13F holders for ENVB?

Yes. Rallies tracks hedge fund and 13F ownership data for ENVB, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ENVB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ENVB. It does not provide personalized investment advice.

ENVB (Enveric Biosciences, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Enveric Biosciences, Inc. Common Stock (ENVB) is a publicly traded Healthcare sector company. As of May 21, 2026, ENVB trades at $2.19 with a market cap of $4.27M and a P/E ratio of -0.16. ENVB moved +6.16% today. Year to date, ENVB is -45.41%; over the trailing twelve months it is -86.42%. Its 52-week range spans $1.71 to $99.90. Rallies surfaces ENVB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ENVB stock?

Hedge funds tracked by Rallies that own ENVB include Two Sigma, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Enveric Biosciences, Inc. Common Stock.

ENVB Key Metrics

Key financial metrics for ENVB
Metric	Value
Price	$2.19
Market Cap	$4.27M
P/E Ratio	-0.16
EPS	$-13.36
Dividend Yield	0.00%
52-Week High	$99.90
52-Week Low	$1.71
Volume	773
Avg Volume	0
Revenue (TTM)	$-411
Net Income	$-8.22M
Gross Margin	0.00%

Top Hedge Funds Holding ENVB

Two Sigma holds 31.87K shares of ENVB, changed +4.05% as of Dec 31, 2024.
Citadel Advisors holds 15.02K shares of ENVB, changed +17.75% as of Dec 31, 2024.
Two Sigma holds 12.14K shares of ENVB, changed -9.26% as of Dec 31, 2024.

Latest ENVB News

Enveric Biosciences Advances EB-003 Toward IND, Reports $1.6M Q1 Loss — May 15, 2026
Enveric Biosciences Patent Challenge Withdrawn, Clears IP Uncertainty — Feb 25, 2026
Enveric's EB-003 Shows Dual 5-HT2A Signaling With β-Arrestin Bias — Feb 19, 2026

Recent ENVB Insider Trades

PASQUALONE FRANK bought 1.00K (~$2.14K) on Sep 15, 2023.

ENVB Analyst Consensus

ENVB analyst coverage data. Average price target: $0.00.

Common questions about ENVB

Who owns ENVB stock?: Hedge funds tracked by Rallies that own ENVB include Two Sigma, Citadel Advisors, and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Enveric Biosciences, Inc. Common Stock.
Does Rallies show 13F holders for ENVB?: Yes. Rallies tracks hedge fund and 13F ownership data for ENVB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ENVB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ENVB. It does not provide personalized investment advice.